| Item | Amount | Y/Y |
|---|---|---|
| Revenue | ¥0.30B | +17.8% |
| Gross profit | ¥0.04B | — |
| Operating income | ¥0.00B | — |
| Net income | ¥0.00B | -13.5% |
| Gross margin | 12.4% | Net margin 1.0% |
| Revenue Q/Q | -4.9% | — |
The filing did not disclose a revenue breakdown for this period.
| Item | Amount | % of revenue |
|---|---|---|
| Cost of revenue | ¥0.26B | 87.6% |
| R&D | ¥0.01B | 3.6% |
| SG&A | ¥0.01B | 3.0% |
| Tax & other | ¥-0.00B | -0.3% |
The Sankey chart shows how revenue splits into cost of revenue, R&D and SG&A, and what remains as profit — clean visuals for research decks and social posts.
维康药业 ・ 大叶股份 ・ 迦南智能 ・ 盛德鑫泰 ・ 万胜智能 ・ 龙利得 ・ 狄耐克 ・ 海昌新材 ・ 华业香料 ・ 谱尼测试 ・ 稳健医疗 ・ 爱克股份
Source: Eastmoney · This page shows public filing data only, not investment advice. · Browse all companies